A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 14, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

September 12, 2023

Conditions

Thyroid Eye Disease

Interventions

DRUG

Teprotumumab

SC administration and IV infusion

Trial Locations (3)

Bascom Palmer Eye Institute - University of Miami, Miami

Barnes Jewish Hospital Washington University, St Louis

Neuro-Eye Clinical Trials, Bellaire